American Society for Reproductive Medicine

01/12/2021 | Press release | Distributed by Public on 01/12/2021 22:48

FDA Updates Information for HCT/P Establishments Regarding the COVID-19 Pandemic

FDA Updates Information for HCT/P Establishments Regarding the COVID-19 Pandemic

Jan 12, 2021
Author: U.S. Food and Drug Administration
Origin: FDA Announcement

The U.S. Food and Drug Administration (FDA) has issued updated information for facilities and medical professionals handling human cell, tissue, or cellular or tissue-based products (HCT/P) with regard to the COVID-19 pandemic, and now, the COVID-19 vaccines.

The FDA emphasizes that there have been no reported cases of transmission of COVID-19 via human cell, tissue, or cellular, or tissue-based products.

See the update, and links to additional information, here.

ASRM Announcements contain information of interest to members about ASRM and its affiliates, NIH, FDA, WHO, or CDC matters.